Testing HDM1005 injection for weight loss in adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your BMI is 28 to 39.9 (meaning you are in the obesity range).
- You have been trying to eat healthier and exercise for at least 3 months, and your weight has not changed by more than 5% in that time.
- You do not have diabetes (type 1, type 2, or any other type).
- You have no history of certain stomach or pancreas problems, and you have not had weight-loss surgery.
- If you could become pregnant, you must use effective birth control during the study and for 60 days after the last dose. If you are a man, you must use effective birth control during the study and for 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
This trial tests a new medication, HDM1002, to help people with excess weight lose weight and keep it off. You may qualify if you have a high BMI or a lower BMI with weight-related health problems, and you have struggled to lose weight through diet and exercise alone.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.